{
    "code": "02023428",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023428",
    "time": "2019-10-25 03:20:23",
    "許可證字號": "衛署藥輸字第023428號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/05\/06",
    "發證日期": "91\/05\/06",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202342806",
    "中文品名": "威博雋持續性藥效錠",
    "英文品名": "WELLBUTRIN SUSTAINED-RELEASE TABLETS 150MG",
    "適應症": "重鬱症、治療尼古丁依賴性，作為戒煙之輔助。",
    "劑型": "121持續性藥效錠",
    "包裝": "2-1000錠盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "BUPROPION HYDROCHLORIDE",
    "主製造廠": {
        "申請商名稱": "0901801100  荷商葛蘭素史克藥廠股份有限公司台灣分公司",
        "申請商地址": "台北市中正區忠孝西路一段66號23-24樓",
        "主製造廠": "",
        "製造廠名稱": "FUS0295100  GLAXOSMITHKLINE LLC."
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "6132061151  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "FPL0010000  GLAXOSMITHKLINE PHARMACEUTICALS S.A.",
            "製造廠廠址": "UL. GRUNWALDZKA 189, 60-322 POZNAN, POLAND",
            "製造廠公司地址": "",
            "製造廠國別": "POLAND",
            "製程": "包裝"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9250001110",
            "成分名稱": "BUPROPION HYDROCHLORIDE",
            "含量描述": "",
            "含量": "150.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "1.1cm*1.1cm 錠劑",
        "特殊劑型": "裸錠",
        "顏色": "白色",
        "特殊氣味": "",
        "刻痕": "無",
        "形狀": "圓凸形",
        "標記一": "GX CH7",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Wellbutrin SR tablets_white-106-12-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023428&Seq=006&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "020234280001-108-08-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023428&Seq=007&Type=9"
        },
        {
            "title": "02023428_Wellbutrin SR 150mg tab MF-107-06-05(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023428&Seq=007&Type=8"
        }
    ]
}